Should a patient with benign prostatic hyperplasia and only a few red blood cells and few white blood cells in the urine be treated with antibiotics for a urinary tract infection?

Do Not Treat with Antibiotics Based on Urinalysis Alone

A patient with BPH who has only a few RBCs and WBCs in the urine without clear UTI symptoms should NOT receive antibiotics, as this likely represents asymptomatic bacteriuria (ABU), which should not be treated in this population. 1

Key Diagnostic Considerations

The presence of "few" RBCs and WBCs on urinalysis does not establish a diagnosis of UTI. According to the 2024 EAU guidelines, asymptomatic bacteriuria should not be screened for or treated in patients with BPH 1. The guidelines explicitly list "patients with a dysfunctional and/or reconstructed lower urinary tract" among those who should NOT be treated for ABU (strong recommendation) 1.

When Antibiotics ARE Indicated

Treatment is only warranted when the patient has symptomatic UTI, defined by:

• Lower urinary tract symptoms: dysuria, frequency, urgency (beyond baseline BPH symptoms)
• Systemic symptoms: fever, rigors, altered mental status
• Flank pain or costovertebral angle tenderness (suggesting pyelonephritis)
• New onset or worsening of symptoms 1

Critical Distinction: BPH vs. UTI Symptoms

This is a common clinical pitfall. Men with BPH already have baseline LUTS (frequency, urgency, weak stream). You must determine if symptoms represent NEW or WORSENING complaints beyond their baseline BPH symptoms 2. The IPSS score can help quantify symptom severity.

Diagnostic Algorithm

If the patient is asymptomatic or has only baseline BPH symptoms:

• Do NOT obtain urine culture
• Do NOT treat with antibiotics
• The few WBCs/RBCs likely represent chronic inflammation from BPH itself 3, 4

If the patient has NEW urinary symptoms:

1. Obtain urine culture before starting antibiotics 1
2. This is a complicated UTI due to structural abnormality (BPH causing obstruction) 1, 5
3. Treat for 7-14 days (14 days if prostatitis cannot be excluded) 1
4. First-line empiric therapy: trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days 1
5. Alternative: fluoroquinolones (only if local resistance <10% and patient hasn't used them in past 6 months) 1

Important Caveats

BPH creates a complicated UTI scenario when infection does occur because:

• The microbial spectrum is broader than uncomplicated UTI 1
• E. coli remains most common (47-48%), but Klebsiella, Pseudomonas, and Enterococcus are more frequent 6, 7, 8
• Antibiotic resistance rates are higher in this population 7, 8
• Treatment duration must be longer (7-14 days vs. 3-5 days for uncomplicated cystitis) 1

The only exception for treating ABU in BPH patients is before urological procedures that breach the mucosa (strong recommendation) 1. In this specific scenario, screen with urine culture and treat documented bacteriuria before the procedure 1.

Avoid This Common Error

Do not reflexively prescribe antibiotics for pyuria or microscopic hematuria in BPH patients. Research shows that 44-47% of men with symptomatic BPH have bacteriuria 6, 8, but treating asymptomatic colonization increases antibiotic resistance without improving outcomes and may eliminate protective bacterial strains 1.